3v9v: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:3v9v. | [[Image:3v9v.png|left|200px]] | ||
{{STRUCTURE_3v9v| PDB=3v9v | SCENE= }} | {{STRUCTURE_3v9v| PDB=3v9v | SCENE= }} | ||
===Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator=== | ===Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator=== | ||
{{ABSTRACT_PUBMED_22225641}} | {{ABSTRACT_PUBMED_22225641}} | ||
Revision as of 13:21, 8 August 2012
Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulatorCrystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator
Template:ABSTRACT PUBMED 22225641
About this StructureAbout this Structure
3v9v is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Furukawa A, Arita T, Fukuzaki T, Satoh S, Mori M, Honda T, Matsui Y, Wakabayashi K, Hayashi S, Araki K, Ohsumi J. Substituents at the naphthalene C3 position of (-)-Cercosporamide derivatives significantly affect the maximal efficacy as PPARgamma partial agonists. Bioorg Med Chem Lett. 2012 Feb 1;22(3):1348-51. Epub 2011 Dec 16. PMID:22225641 doi:10.1016/j.bmcl.2011.12.066